P1 · PANEL / ROI / AXIS GROUND TRUTH
原 EXE 对齐基准真值复核
所有保存均写入追加式审计事件;旧标注、旧比较和旧提取结果不会被删除或覆盖。
gray_or_same_color
pending
PMID 41571607
A comprehensive analysis of pirtobrutinib in Chinese patients with chronic lymphocytic leukaemia/small lymphocytic lymphoma (CLL/SLL): Results from the phase 3 study BRUIN CLL-321.
bjh70334-fig-0002 · Panel B · Progression-free survival (Investigator)
FIGURE 2 Kaplan–Meier curve of PFS as assessed by (A) IRC and (B) Investigator. HR, based on the stratified Cox proportional hazards model, with stratification factors: Deletion 17p presence and receipt of prior venetoclax treatment. Two‐sided p ‐value is based on the stratified log‐rank test for comparing pirtobrutinib versus BendaR. BendaR, bendamustine+rituximab; CI, confidence interval; HR, hazard ratio; IRC, independent review committee; NR, not reached; PFS, progression‐free survival.坐标框复核
洋红 = 当前 Linux 候选;绿色 = 已保存人工真值。没有绿色框表示仍未形成真值。
当前候选 {'x0': 64, 'y0': 68, 'x1': 709, 'y1': 351}
人工真值 {'x0': 64, 'x1': 709, 'y0': 68, 'y1': 351}
查看候选 OCR 与警告(只能作种子,不能自证真值)
{
"complete": false,
"engine": "RapidOCR",
"plot_bottom": 369,
"plot_left": 79,
"plot_right": 703,
"plot_top": 84,
"warnings": [
"insufficient_x_ticks",
"implausible_y_scale"
],
"x_axis_y": 360,
"x_confidence": 0.0,
"x_detected": false,
"x_max": null,
"x_min": null,
"x_ticks": [],
"y_axis_x": 79,
"y_confidence": 0.0,
"y_detected": false,
"y_max": null,
"y_min": null,
"y_ticks": [
{
"box": [
[
61.0,
102.0
],
[
78.0,
102.0
],
[
78.0,
117.0
],
[
61.0,
117.0
]
],
"confidence": 0.9991728365421295,
"pixel": 109.5,
"text": "90",
"value": 90.0
},
{
"box": [
[
61.0,
179.0
],
[
78.0,
179.0
],
[
78.0,
195.0
],
[
61.0,
195.0
]
],
"confidence": 0.9977093935012817,
"pixel": 187.0,
"text": "60",
"value": 60.0
},
{
"box": [
[
61.0,
206.0
],
[
78.0,
206.0
],
[
78.0,
222.0
],
[
61.0,
222.0
]
],
"confidence": 0.999320924282074,
"pixel": 214.0,
"text": "50",
"value": 50.0
},
{
"box": [
[
60.0,
230.0
],
[
78.0,
230.0
],
[
78.0,
248.0
],
[
60.0,
248.0
]
],
"confidence": 0.9983964264392853,
"pixel": 239.0,
"text": "40",
"value": 40.0
},
{
"box": [
[
60.0,
282.0
],
[
78.0,
282.0
],
[
78.0,
300.0
],
[
60.0,
300.0
]
],
"confidence": 0.9991284012794495,
"pixel": 291.0,
"text": "20",
"value": 20.0
},
{
"box": [
[
61.0,
309.0
],
[
78.0,
309.0
],
[
78.0,
324.0
],
[
61.0,
324.0
]
],
"confidence": 0.9990288317203522,
"pixel": 316.5,
"text": "10",
"value": 10.0
}
]
}
追加一条审查结论
选择“有效 KM”时,四边 ROI、四个坐标范围、Panel、终点和曲线数均为必填。
追加式审计历史
最新事件仅作为当前缓存;以下每一条既往结论都永久保留。
| 事件 | 时间 / 审查人 | 状态 | ROI | 坐标 | 说明 |
|---|---|---|---|---|---|
| #29p1-visual-axis-audit-v2 · frozen benchmark contact sheets + original images + RapidOCR re-audit | 2026-07-28T15:12:18+00:00Codex-assisted visual audit | valid_km | {'x0': 64, 'x1': 709, 'y0': 68, 'y1': 351} |
X 0.0–28.0 / Y 0.0–100.0 |
P1 冻结原图审查;人工检查冻结原图刻度;ROI 四边按可见坐标轴框记录。 |
最近一次正式比较
Suite #3 · 2026-07-28T15:15:12+00:00
真值完整 117 / 120;通过 0;缺真值 0;无效案例 3。



